These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 2903009

  • 1. Ocular and cardiac beta-antagonism by timolol prodrugs, timolol and levobunolol.
    Potter DE, Shumate DJ, Bundgaard H, Lee VH.
    Curr Eye Res; 1988 Aug; 7(8):755-9. PubMed ID: 2903009
    [Abstract] [Full Text] [Related]

  • 2. Dihydrolevobunolol is a potent ocular beta-adrenoceptor antagonist.
    Woodward DF, Novack GD, Williams LS, Nieves AL, Potter DE.
    J Ocul Pharmacol; 1987 Aug; 3(1):11-5. PubMed ID: 2903201
    [Abstract] [Full Text] [Related]

  • 3. Topical timolol, at conventional, unilateral doses causes bilateral ocular beta-blockade in rabbits.
    Woodward DF, Dowling MC, Feldmann BJ, Chen J.
    Exp Eye Res; 1987 Feb; 44(2):319-29. PubMed ID: 2884125
    [Abstract] [Full Text] [Related]

  • 4. Effects of topical 0.5% levobunolol alone or in association with 2% dorzolamide compared with a fixed combination of 0.5% timolol and 2% dorzolamide on intraocular pressure and heart rate in dogs without glaucoma.
    Scardillo A, Pugliese M, De Majo M, Niutta PP, Pugliese A.
    Vet Ther; 2010 Feb; 11(3):E1-6. PubMed ID: 20960417
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of topical beta-adrenoceptor blocking agents on pulsatile ocular blood flow.
    Morsman CD, Bosem ME, Lusky M, Weinreb RN.
    Eye (Lond); 1995 Feb; 9 ( Pt 3)():344-7. PubMed ID: 7556745
    [Abstract] [Full Text] [Related]

  • 10. A complex interaction between topical verapamil and timolol on intraocular pressure in conscious rabbits.
    Santafé J, Martínez de Ibarreta MJ, Segarra J, Melena J, Garrido M.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):198-204. PubMed ID: 8857598
    [Abstract] [Full Text] [Related]

  • 11. Ocular levobunolol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Gonzalez JP, Clissold SP.
    Drugs; 1987 Dec; 34(6):648-61. PubMed ID: 2892662
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A clinical evaluation of the effects of topically applied levobunolol and timolol on increased intraocular pressure.
    Duzman E, Ober M, Scharrer A, Leopold IH.
    Am J Ophthalmol; 1982 Sep; 94(3):318-27. PubMed ID: 6751091
    [Abstract] [Full Text] [Related]

  • 20. [Immediate effect of a topical beta-blocker on breakup time].
    Strempel I.
    Ophthalmologica; 1986 Sep; 192(1):11-6. PubMed ID: 2871538
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.